48 related articles for article (PubMed ID: 12944068)
1. Ethics of genetic and biomarker test disclosures in neurodegenerative disease prevention trials.
Kim SY; Karlawish J; Berkman BE
Neurology; 2015 Apr; 84(14):1488-94. PubMed ID: 25762713
[TBL] [Abstract][Full Text] [Related]
2. An ESMO-EORTC position paper on the EU clinical trials regulation and EMA's transparency policy: making European research more competitive again.
Dittrich C; Negrouk A; Casali PG;
Ann Oncol; 2015 May; 26(5):829-832. PubMed ID: 25802239
[No Abstract] [Full Text] [Related]
3. Involving patients in enrolment decisions for acute myocardial infarction trials.
Dickert NW; Miller FG
BMJ; 2015 Jul; 351():h3791. PubMed ID: 26223782
[TBL] [Abstract][Full Text] [Related]
4. Informed Consent: A Clinical Trials Perspective.
Hammer MJ; Eckardt P; Barton-Burke M
Oncol Nurs Forum; 2016 Nov; 43(6):694-696. PubMed ID: 27768140
[TBL] [Abstract][Full Text] [Related]
5. Surrogate consent for genetic testing, the reconsent process, and consent for long-term outcomes in acute respiratory distress syndrome trials.
Smart A; Thompson BT; Needham DM; Hopkins RO; Williams A; Burnham EL; Moss M;
Am J Respir Crit Care Med; 2013 Dec; 188(11):1370-3. PubMed ID: 24289781
[No Abstract] [Full Text] [Related]
6. Conflicts among multinational ethical and scientific standards for clinical trials of therapeutic interventions.
Kolman JM; Wray NP; Ashton CM; Wenner DM; Jarman AF; Brody BA
J Law Med Ethics; 2012; 40(1):99-121. PubMed ID: 22458466
[TBL] [Abstract][Full Text] [Related]
7. Must the capacitous young person also be competent to provide consent for treatment and research?
Wheeler R
Arch Dis Child; 2024 Mar; 109(4):265-266. PubMed ID: 38123943
[No Abstract] [Full Text] [Related]
8. Tackling treatment uncertainties together: the evolution of the James Lind Initiative, 2003-2013.
Chalmers I; Atkinson P; Fenton M; Firkins L; Crowe S; Cowan K
J R Soc Med; 2013 Dec; 106(12):482-91. PubMed ID: 23824330
[No Abstract] [Full Text] [Related]
9. Informed consent in clinical trials in critical care: experience from the PAC-Man Study.
Harvey SE; Elbourne D; Ashcroft J; Jones CM; Rowan K
Intensive Care Med; 2006 Dec; 32(12):2020-5. PubMed ID: 17019555
[TBL] [Abstract][Full Text] [Related]
10. Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment.
Polman CH; Reingold SC; Barkhof F; Calabresi PA; Clanet M; Cohen JA; Cutter GR; Freedman MS; Kappos L; Lublin FD; McFarland HF; Metz LM; Miller AE; Montalban X; O'Connor PW; Panitch H; Richert JR; Petkau J; Schwid SR; Sormani MP; Thompson AJ; Weinshenker BG; Wolinsky JS
Neurology; 2008 Mar; 70(13 Pt 2):1134-40. PubMed ID: 18362273
[TBL] [Abstract][Full Text] [Related]
11. Consent in Alzheimer's disease research: risk/benefit factors.
Beattie BL
Can J Neurol Sci; 2007 Mar; 34 Suppl 1():S27-31. PubMed ID: 17469678
[TBL] [Abstract][Full Text] [Related]
12. Provision of consent.
Chalmers I
Lancet; 2003 Aug; 362(9384):663-4. PubMed ID: 12944068
[No Abstract] [Full Text] [Related]
13. What do people at risk for Alzheimer disease think about surrogate consent for research?
Schenk DB; Gilman S
Neurology; 2006 Jun; 66(11):1785-6. PubMed ID: 16769971
[No Abstract] [Full Text] [Related]
14. What do people at risk for Alzheimer disease think about surrogate consent for research?
Kim SY; Kim HM; McCallum C; Tariot PN
Neurology; 2005 Nov; 65(9):1395-401. PubMed ID: 16275826
[TBL] [Abstract][Full Text] [Related]
15. Does informed consent to research require comprehension?
Sreenivasan G
Lancet; 2003 Dec; 362(9400):2016-8. PubMed ID: 14683665
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
